Literature DB >> 28892087

Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL.

F El Chaer1,2, N Holtzman1,2, E Binder1,2, N C Porter3, Z N Singh4, M Koka4, A P Rapoport1,2, A Emadi1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28892087     DOI： 10.1038/bmt.2017.191

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  Acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Mary V Relling; James R Downing
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

2.  Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.

Authors:  Benjamin Y Lu; Shivani U Thanawala; Kelly C Zochowski; Michael J Burke; William L Carroll; Teena Bhatla
Journal:  Leuk Lymphoma       Date:  2016-01-04

3.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

4.  Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia.

Authors:  Mohammad Bakr; Walid Rasheed; Said Y Mohamed; Fahad Al-Mohareb; Naeem Chaudhri; Fahad Al-Sharif; Hazza Al-Zahrani; Ghuzayel Al-Dawsari; Abu Jafar Saleh; Amr Nassar; Shad Ahmed; Assem Elghazaly; Syed O Ahmed; Khalid Ibrahim; Wahiba Chebbo; Ghada M El Gohary; Muhamad H Al Mahayni; Fazal Hussain; Zubeir Nurgat; Tusneem Ahmed Elhassan; Claudia U Walter; Mahmoud Aljurf
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-21       Impact factor: 5.742

5.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

6.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

7.  A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.

Authors:  Michael J Burke; Jatinder K Lamba; Stanley Pounds; Xueyuan Cao; Yogita Ghodke-Puranik; Bruce R Lindgren; Brenda J Weigel; Michael R Verneris; Jeffrey S Miller
Journal:  Am J Hematol       Date:  2014-06-27       Impact factor: 10.047

8.  Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.

Authors:  Matthew P McCormack; Benjamin J Shields; Jacob T Jackson; Chayanica Nasa; Wei Shi; Nicholas J Slater; Cedric S Tremblay; Terence H Rabbitts; David J Curtis
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

9.  Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy.

Authors:  Bhavana Bhatnagar; Vu H Duong; Theodore S Gourdin; Michael L Tidwell; Ching Chen; Yi Ning; Ashkan Emadi; Edward A Sausville; Maria R Baer
Journal:  Leuk Lymphoma       Date:  2014-02-04

10.  Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

Authors:  Daniel J DeAngelo; Daohai Yu; Jeffrey L Johnson; Steven E Coutre; Richard M Stone; Alison T Stopeck; Jon P Gockerman; Beverly S Mitchell; Frederick R Appelbaum; Richard A Larson
Journal:  Blood       Date:  2007-03-07       Impact factor: 22.113
View more
  4 in total

Review 1.  Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.

Authors:  Premal D Lulla; Maksim Mamonkin; Malcolm K Brenner
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

Review 2.  T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.

Authors:  Valentina Cordo'; Jordy C G van der Zwet; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Blood Cancer Discov       Date:  2020-11-24

3.  Novel Targeted Therapies for T-Cell Malignancies.

Authors:  Melania Tesio
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

4.  Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.

Authors:  Juliette Roels; Morgan Thénoz; Bronisława Szarzyńska; Mattias Landfors; Stien De Coninck; Lisa Demoen; Lien Provez; Anna Kuchmiy; Steven Strubbe; Lindy Reunes; Tim Pieters; Filip Matthijssens; Wouter Van Loocke; Büşra Erarslan-Uysal; Paulina Richter-Pechańska; Ken Declerck; Tim Lammens; Barbara De Moerloose; Dieter Deforce; Filip Van Nieuwerburgh; Laurence C Cheung; Rishi S Kotecha; Marc R Mansour; Bart Ghesquière; Guy Van Camp; Wim Vanden Berghe; Jerzy R Kowalczyk; Tomasz Szczepański; Utpal P Davé; Andreas E Kulozik; Steven Goossens; David J Curtis; Tom Taghon; Małgorzata Dawidowska; Sofie Degerman; Pieter Van Vlierberghe
Journal:  Blood Cancer Discov       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.